| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |